Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

14 Results

Guidelines and Advice

The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary

Status: Current
ID: PET ES-15

Jan 2014

Guidelines and Advice

The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary

Status: Current
ID: PET ES-14

Jan 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2014

Status: Current
ID: PET 2014-1

Dec 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to Dec 2013

Status: Current
ID: PET 2013-2

Sep 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2012 to June 2013

Status: Current
ID: PET 2013-1

May 2014

Guidelines and Advice

Lung Cancer Imaging Guidelines: Integration with the Lung Cancer Diagnosis and Staging Clinical Pathway - Full Document

Status: Current
ID: GL-C50-11

Jan 2014

Guidelines and Advice

Surveillance of Patients with Stage I, II, III, or Resectable IV Melanoma Who Were Treated with Curative Intent

Status: Current
ID: 8-7
Version: 2

Mar 2023

Guidelines and Advice

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program

Status: Current

Jun 2014

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2022

Status: Current
ID: PET 2022-1

Jan 2023

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2022

Status: Current
ID: PET 2022-2

Jun 2023

Guidelines and Advice

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Status: Current
ID: GL-END-C50-35

Aug 2023

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2023

Status: Current
ID: PET 2023-1

Nov 2023

Pages